11
1 h 3Q21 Earnings presentation

3Q21 Earnings presentation - api.mziq.com

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 3Q21 Earnings presentation - api.mziq.com

1

h

3Q21Earnings presentation

Page 2: 3Q21 Earnings presentation - api.mziq.com

2

Disclaimer

This is a brief presentation of the main highlights of the quarterly information of Hospital Mater Dei SA (“Mater Dei” or “Company”) for the three-month& nine-month period ended on September 30, 2021 (“Financial Statements”).

This presentation has been summarized and is not intended to be complete. The Company's shareholders and potential investors must always read thispresentation together with the Quarterly Information.

This presentation was prepared for informational purposes only and should not be taken as a request for an offer to buy or sell any securities and shouldnot be treated as an investment recommendation.

No statement, express or otherwise, is made regarding the accuracy, certainty or comprehensiveness of the information contained in this presentation.The Company's past performance is not an indicative of future results. This presentation should not be used as the basis for any agreement or contract.

Information regarding the Mater Dei Hospital, its activities, economic and financial position and the risks inherent to its activities, as well as its financialstatements, can be found on the world wide web, on the Mater Dei website (https://ri.materdei.com.br/en)

Page 3: 3Q21 Earnings presentation - api.mziq.com

3

CEO comments

Corporate Education

Mater Dei Salvador

• Inauguration on the 1st semester of 2022

Porto Dias Group

• Closing of the Porto Dias Group

A3Data

Purchase of 50,1% of A3Data• Data analytics and artificial intelligence• Application in new compensation models

• Launch of the postgraduate course in Sports Medicine;

• Launch of the Robotics course.

Ratings

AA+.br

(Company and 1st

Debenture’s Issuance)

AA(br)

(Company)

Page 4: 3Q21 Earnings presentation - api.mziq.com

4

2.562.39

2.68

2.39 2.45

3Q20 2Q21 3Q21 9M20 9M21

515646 574 510

615

63.4%74.7%

67.9%59.9%

70.3%

3Q20 2Q21 3Q21 9M20 9M21

# of operational beds % occupancy rate

Operational highlights

Avg. Operational beds and occupancy rate % change in number of patients-day vs. 3Q20

1. Annualized Gross revenue by used bed; 2. Values from September onwards were measured on a weekly basis

Average Ticket – R$ Mm¹ Mater Dei’s COVID-192 patients

10.5%

27.4%

46.1%

19.2%

4Q20 1Q21 2Q21 3Q21

+12%

-26.9 pp

141

196

55

Jan-21 Feb-21 Mar-21 Apr-21 May-21 Jun-21 Jul-21 Aug-21 Sep-21

COVID-19 Patients 1Q21 Average 2Q21 Average 3Q21 Average

Page 5: 3Q21 Earnings presentation - api.mziq.com

5

195269 240

510

736

3Q20 2Q21 3Q21 9M20 9M21

Revenue

Net Revenue – R$ Mn

+ 23.1%

+ 44.5%

- 10.6%

Page 6: 3Q21 Earnings presentation - api.mziq.com

6

113150 156

57.8% 55.8%64.9%

3Q20 2Q21 3Q21

Costs and Expenses

Cost of services provided – R$ Mn

Net operating expenses – R$ Mn

% net revenue

% netrevenue

7.2 pp

9.1 pp

327444

64.3%60.3%

9M20 9M21

- 3.9 pp

2635

24

13.5% 13.1%

10.2%

3Q20 2Q21 3Q21

85 95

16.6%

12.9%

9M20 9M21

- 3.7 pp- 3.4 pp

- 2,9 pp

Employees per operational bed

5.6 5.66.2

3Q20 2Q21 3Q21

+10%

Page 7: 3Q21 Earnings presentation - api.mziq.com

7

EBITDA

6693 69

126

224

33.7% 34.6%28.8%

24.8%30.5%

3Q20 2Q21 3Q21 9M20 9M21

- 5.0 pp

- 5.8 pp+ 5.7 pp

% EBITDAmargin

- 25.6%

+ 5,0%

+ 77.2%

EBITDA and EBITDA Margin – R$ Mn

Page 8: 3Q21 Earnings presentation - api.mziq.com

8

3753

4459

123

18.8% 19.8% 18.2%

11.5%

16.8%

3Q20 2Q21 3Q21 9M20 9M21

Net Income and Cash Flow

Cash Flow – R$ MnNet Income – R$ Mn

% netmargin

1. Cash, cash equivalents and financial investments

- 0.6 pp

- 1.6 pp

+ 5.3 pp

Cash and Cash Equivalents Financial Investments

872 866

513

83 (109)

(25) 20

488

1,384 1,353

Cash and Cashequivalents¹

Jun/21

Operational Investimento (w/oyields)

Funding Sources Investimentsyields

Cash and Cashequivalents¹

Sep/21

- 18.0%

+ 19.0%

+ 110.7%

Page 9: 3Q21 Earnings presentation - api.mziq.com

9

6631 44

117

26%

12%17%

45%

Less than 1 year 2 to 3 years 4 to 5 years Over 5 years

Debt - R$ Million % of total debt

Debt and leverage

Net Debt / EBITDA

Debt amortization schedule - R$ Mn

Average amortization term = 5.6 years

220 281 258282

1,384 1,353

3Q20 2Q21 3Q21

Gross Debt Cash and Cash Equivalents¹

1. Cash, cash equivalents and investments

(0.2)(4.3) (4.3)

Net Debt/ EBITDA (LTM)

In November: 1st debenture issue totaled R$ 700 million and rate interest of CDI + 1.60%

Page 10: 3Q21 Earnings presentation - api.mziq.com

10

Investor Relations –Next Events

Date Event

November 25th Safra - 7th Safra Healthcare Conference

November 29th Itaú BBA - Hospital’s Day

December 02th JPM - Brazil Opportunities Conference 2021

Website: ri.materdei.com.br/en/E-mail: [email protected]

Page 11: 3Q21 Earnings presentation - api.mziq.com

11